Not checkedNot checked for notices yet.
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
Laetitia Seguin, Soline Odouard, Francesca Corlazzoli and 17 more
Communications Biology · 2021
doi:10.1038/s42003-021-02258-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Seguin et al demonstrated in glioblastoma patient-derived stem cells that a subset of glioblastoma tumours is dependent on macropinocytosis mediated survival through a Galectin-3/RAB10/beta 1 integrin axis. They used both genetic and pharmacologic inhibition of Galectin-3 in vivo and in vitro to identify underlying mechanisms and define a Galectin-3/macropinocytosis molecular signature, which could inform the development of anti-tumour therapeutic strategies.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.